Andrew Howden

Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC.

IQVIA, Inc. provides information technology solutions to the healthcare industry. It offers research and development, enterprise information management, commercial analytics, market analysis, patient consent system, content management, and other related solutions. The company was founded by Bill Frohlich and David Dubow in 1954 and is headquartered in Danbury, CT.

IMS Health Holdings, Inc. operates as a global information and technology services company. It provides clients in the healthcare industry including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community, offering a range of solutions. It specializes in collections of healthcare information in the world, spanning sales, prescription and promotional data, medical claims, electronic medical records, and social media. It operates through the following geographical segments: Americas, Europe, the Middle East and Africa, Asia Pacific; and Corporate and Other. The company was founded on October 23, 2009 and is headquartered in Danbury, CT.

Bausch & Lomb Australia Pty Ltd. manufactures and distributes prescription medicines. It offers consumer healthcare, prescription, aesthetic skin and eyecare. The company was founded in 2006 and is headquartered in Chatswood, Australia.

IQVIA RDS Pty Ltd. engages in the provision of clinical trials and studies for the pharmaceutical industry. It offers biostatistics, clinical monitoring and site management, data management, medical writing, project management, and regulatory services. The company was founded in 1993 and is headquartered in Sydney, Australia.

ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore.